Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells

被引:69
作者
Yan, Bin [2 ]
Fu, Qihong [3 ]
Lai, Lihua [1 ]
Tao, Xinran [1 ]
Fei, Yanghonghong [1 ]
Shen, Jiangen [1 ]
Chen, Zuodong [2 ]
Wang, Qingqing [1 ]
机构
[1] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China
[2] Ningbo First Hosp, Dept Oral & Maxillofacial Surg, Ningbo 315000, Zhejiang, Peoples R China
[3] Hangzhou Normal Univ, Dept Stomatol, Clin Med Coll, Hangzhou 310036, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
microRNA; 99a; oral squamous cell carcinomas; cell survival; mammalian target of rapamycin; MAMMALIAN TARGET; EXPRESSION; TONGUE; RAPAMYCIN; MTOR; APOPTOSIS; PATHWAY; HEAD; INHIBITOR; PROGNOSIS;
D O I
10.3892/mmr.2012.971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
microRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression by either translational inhibition or mRNA degradation. miRNAs play pivotal roles in physiological functioning and pathological progression. The function of microRNA-99a (miR-99a) in oral squamous cell carcinoma (OSCC) remains unclear. In the present study, we investigated the roles of miR-99a in OSCC development and the underlying mechanisms in 25 cases of primary OSCC tissues and Tca-8113 cells. The cells were analyzed using FACS analysis and western blotting. Results showed that the expression levels of miR-99a were markedly decreased in OSCC tissues compared with the adjacent non-tumor tissues (n=25). The results of in vitro experiments showed that miR-99a mimics significantly inhibited the proliferation of Tca-8113 cells, a tongue squamous carcinoma cell I me, and that miR-99a mimics markedly induced the apoptosis of Tca-8113 cells. Furthermore, we demonstrated that mammalian target of rapamycin (mTOR) was directly targeted by miR-99a, as the overexpression of miR-99a in Tca-8113 cells downregulated the protein expression level of mTOR. Thus, our findings suggest that the downregulation of miR-99a in OSCC tissues is associated with tumor development. miR-99a regulates the growth and survival of OSCC cells and may be exploited as a biomarker and therapeutic target for patients with OSCC.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 39 条
  • [1] Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
    Aissat, Nasredine
    Le Tourneau, Christophe
    Ghoul, Aida
    Serova, Maria
    Bieche, Ivan
    Lokiec, Francois
    Raymond, Eric
    Faivre, Sandrine
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 305 - 313
  • [2] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [3] Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
    Catto, James W. F.
    Miah, Saiful
    Owen, Helen C.
    Bryant, Helen
    Myers, Katie
    Dudziec, Ewa
    Larre, Stephane
    Milo, Marta
    Rehman, Ishtiaq
    Rosario, Derek J.
    Di Martino, Erica
    Knowles, Margaret A.
    Meuth, Mark
    Harris, Adrian L.
    Hamdy, Freddie C.
    [J]. CANCER RESEARCH, 2009, 69 (21) : 8472 - 8481
  • [4] Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo
    Chang, Kwang-Yu
    Tsai, Shan-Yin
    Wu, Ching-Ming
    Yen, Chia-Jui
    Chuang, Bin-Fay
    Chang, Jang-Yang
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (22) : 7116 - 7126
  • [5] The mTOR (Mammalian Target of Rapamycin) Kinase Maintains Integrity of mTOR Complex 2
    Chen, Chien-Hung
    Sarbassov, Dos D.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (46) : 40386 - 40394
  • [6] MicroRNAs modulate hematopoietic lineage differentiation
    Chen, CZ
    Li, L
    Lodish, HF
    Bartel, DP
    [J]. SCIENCE, 2004, 303 (5654) : 83 - 86
  • [7] PI3K-AKT-mTOR pathway and cancer
    Coutte, Laetitia
    Dreyer, Chantal
    Sablin, Marie-Paule
    Faivre, Sandrine
    Raymond, Eric
    [J]. BULLETIN DU CANCER, 2012, 99 (02) : 173 - 180
  • [8] mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E
    Fingar, DC
    Richardson, CJ
    Tee, AR
    Cheatham, L
    Tsou, C
    Blenis, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (01) : 200 - 216
  • [9] MicroRNA expression and function in cancer
    Garzon, Ramiro
    Fabbri, Muller
    Cimmino, Amelia
    Calin, George A.
    Croce, Carlo M.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2006, 12 (12) : 580 - 587
  • [10] MicroRNA and oral cancer: Future perspectives
    Gomes, Carolina C.
    Gomez, Ricardo S.
    [J]. ORAL ONCOLOGY, 2008, 44 (10) : 910 - 914